Systematic review and Meta-analysis of efficacy and safety of Huachansu in treating cancer-related pain.
10.19540/j.cnki.cjcmm.20190304.003
- Author:
Jing XU
1
;
Shu-Shu QIAN
1
;
Yao-Guo CHEN
1
;
Dong-Yun LI
1
;
Qian YAN
2
Author Information
1. Dongzhimen Hospital,Beijing University of Chinese Medicine Beijing 100700,China.
2. the First Medical College of Guangzhou University of Chinese Medicine Guangzhou 510405,China.
- Publication Type:Journal Article
- Keywords:
Huachansu;
Meta-analysis;
cancer-related pain;
systematic review
- MeSH:
Amphibian Venoms;
therapeutic use;
Cancer Pain;
drug therapy;
Humans;
Quality of Life;
Randomized Controlled Trials as Topic
- From:
China Journal of Chinese Materia Medica
2019;44(12):2627-2636
- CountryChina
- Language:Chinese
-
Abstract:
To evaluate the effectiveness and safety of Huachansu in the treatment of cancer-related pain,four Chinese databases( CNKI,VIP,Wan Fang,Sino Med) and three English databases( Cochrane Library,Medline,PubMed) were systematically and comprehensively retrieved since the establishment of each database to October 2018. Randomized controlled trials( RCTs) for the treatment of cancer-related pain with Huachansu were screened out according to pre-established inclusion criteria and exclusion criteria. Rev Man5. 3 software was used for Meta-analysis. A total of 241 articles were retrieved,and finally 10 studies were included. The total sample size was 1 293,including 648 in the experimental group and 645 in the control group. The overall quality of the included studies was generally low. The results of Meta-analysis showed that Huachansu combined with Western medicine acesodynes was superior to the single use of Western medicine acesodynes in the treatment of short-term pain relief,improvement of quality of life and reduction of constipation,nausea and vomiting,dizziness,drowsiness,anorexia and other adverse reactions. And it also has the advantage of a shorter onset time and longer duration time of analgesia,but cannot reduce the incidence of dysuria. Based on the findings,Huachansu had a certain effect in the treatment of cancer-related pain,and a significant positive effect on the improvement of quality of life and the reduction of adverse reactions. No serious adverse reactions occurred. However,due to the small number of studies included,the low quality of the included studies,published biases and other restrictions,the evidence in this study has a low quality,and the conclusion shall be adopted with caution. The effectiveness and safety of Huachansu in the treatment of cancer-related pain remained to be further confirmed in the future with a well-designed,rigorous,and standardized report,with a large sample size,multiple centers,and sufficient follow-up time for randomized controlled trials.
